BCL2 and cancer: In human targets, AgNPs bound robustly to Bcl-2 (−58.21 kcal/mol), an anti-apoptotic protein, indicating potential to shift the apoptotic balance and induce cancer cell death, consistent with reports of mitochondrial disruption (Guo et al. 2023; Takáč et al. 2023).